Free Trial

Verve Therapeutics (VERV) SEC Filings & 10K Form

Verve Therapeutics logo
$11.03 -0.03 (-0.27%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$11.05 +0.02 (+0.22%)
As of 07/11/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Verve Therapeutics SEC Filings

DateFilerForm TypeView
06/25/2025
6:00 AM
Verve Therapeutics (Subject)
Form SC 14D9
06/25/2025
5:10 AM
ELI LILLY & Co (Filed by)
Verve Therapeutics (Subject)
Form SC TO-T
06/17/2025
6:18 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
3:17 PM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
11:15 PM
Verve Therapeutics (Filer)
Form EFFECT
05/14/2025
6:30 AM
Verve Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2025
6:15 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
6:45 AM
Verve Therapeutics (Filer)
Form DEFA14A
04/25/2025
6:48 AM
Verve Therapeutics (Filer)
Form ARS
04/25/2025
6:30 AM
Verve Therapeutics (Filer)
Form DEF 14A
04/17/2025
4:40 PM
BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
Form SCHEDULE 13G/A
04/14/2025
6:15 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
7:57 AM
Verve Therapeutics (Filer)
Form POS AM
02/27/2025
7:16 AM
Verve Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
6:45 AM
Verve Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
6:24 AM
Verve Therapeutics (Filer)
Form POSASR
02/27/2025
6:15 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
6:53 AM
STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
Form SCHEDULE 13G
01/10/2025
8:24 PM
ARK Investment Management LLC (Filed by)
Verve Therapeutics (Subject)
Form SCHEDULE 13G/A
01/10/2025
8:00 AM
Ashe Andrew D. (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Nickerson Joan (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Kathiresan Sekar (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Lister Troy (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Politi Jason (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
3:30 PM
Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
4:23 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Verve Therapeutics (Subject)
Form SC 13G
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
11/05/2024
6:15 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
6:30 AM
Verve Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
12:52 PM
VANGUARD GROUP INC (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
10/16/2024
12:06 PM
STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
Form SC 13G
09/09/2024
3:36 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
08/08/2024
6:30 AM
Verve Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:15 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VERV) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners